Israeli generics giant Teva Pharmaceutical (NYSE: [[ticker:TEVA]]) announced Thursday that it had appointed Eli Kalif as its new executive vice president and chief financial officer. Kalif, who was most recently a senior vice president, finance, at Flex (NASDAQ: [[ticker:FLEX]]), a US technological manufacturer, succeeds Mike McClellan, who held the role for the past two years.
Author: Sarah de Crescenzo
Sarah is Xconomy's San Diego-based editor. Prior to joining the team in 2018, she wrote about startups, tech and finance at the San Diego Business Journal. Her decade of full-time news experience includes coverage of subjects including campaign finance, crime and courts as a reporter and editor at outlets throughout California, including the Orange County Register.
She earned a bachelor's degree in English Literature at UC San Diego, where she wrote for the student newspaper and played collegiate lacrosse. In 2019, she earned an MBA at UC Irvine.
View all posts by Sarah de Crescenzo
